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Peak oxygen uptake (peak VO2) has been suggested as a causal risk factor for future hypertension. 
Oxygen uptake at ventilatory threshold (VO2 at VT), is a proxy for peak VO2, but its relationship 
with incident hypertension has not been previously investigated. VO2 at VT was determined at 
baseline during submaximal exercise testing using respiratory gas analyzers in the Kuopio Ischemic 
Heart Disease cohort of 1,360 middle-aged men without hypertension, and its relationship with 
incident hypertension risk was assessed. During a median follow-up of 25.1 years, there were 217 
incident cases of new onset hypertension. This study suggested that in middle-aged Caucasian men, 
VO2 at VT is inversely associated with future risk of hypertension. 
Peak oxygen uptake (VO2), a measure of cardiorespiratory fitness (CRF), is considered the gold 
standard index of aerobic capacity.1 Peak VO2 has been consistently shown to be inversely and 
independently associated with incident cardiovascular disease (CVD) as well as CVD mortality.2, 3 
Emerging evidence from large-scale epidemiological cohorts also demonstrate peak VO2 to be 
consistently associated with future hypertension risk and it has been suggested to be a causal risk factor.4, 
5 Hypertension is an established risk factor for CVD and is included in the standard cardiovascular risk 
assessment panel.6 Oxygen uptake at ventilatory threshold (VO2 at VT), another cardiopulmonary exercise 
testing (CPX) parameter and often referred to as the anaerobic threshold, is assessed at submaximal levels 
of CPX.7 VO2 at VT is considered as a measure of cardiovascular fitness and a reliable index of aerobic 
capacity,1 and has been suggested to be protective of fatal cardiovascular outcomes as well as all-cause 
mortality.8 Previous findings have suggested VO2 at VT to be a suitable proxy for peak VO2.
8 Though 
peak VO2 is a gold standard measure of aerobic capacity, some individuals are unable to achieve this VO2 
level due to exercise-related limitations such as musculoskeletal problems. In such instances, VO2 at VT, 
which can be assessed safely at submaximal exercise levels, may be used as a suitable replacement for the 
assessment of maximal VO2. To our knowledge, the nature of the relationship between VO2 at VT and 
future hypertension risk in general populations has not been previously investigated. We aimed to assess 
the nature and magnitude of the association between VO2 at VT and incident hypertension using the 
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established Kuopio Ischemic Heart Disease (KIHD) population-based cohort comprising healthy middle-
aged men from eastern Finland.  
Participants in the study were men aged 42-61 years recruited into the Kuopio Ischemic Heart Disease 
(KIHD) study, a prospective epidemiologic study of the incidence of cardiovascular and other related 
outcomes among Finnish adults. The institutional review board of the University of Eastern Finland 
approved the study, and each participant provided written informed consent. Detailed description of blood 
sample collection, physical measurements, as well as measurements of covariates have been reported 
previously.9 VO2 at VT as well as peak VO2 were assessed using a respiratory gas exchange analyzer 
(Medical Graphics, MCG, St. Paul, Minnesota), of which details have been reported in a recent report.8 
Incident hypertension was defined as a physician diagnosis of hypertension, systolic blood pressure (SBP) 
≥ 140 mm Hg and/or diastolic BP ≥ 90 mm Hg, or use of anti-hypertensive medication (beta-blockers, 
calcium channel blockers, diuretics or angiotensin-converting-enzyme inhibitor/angiotensin receptor 
antagonists). All physicians or evaluators who assessed follow-up events were blinded to baseline data. 
All BP measurements including follow-up data were measured under standardized conditions. Baseline 
BP measurements were assessed after a supine rest of 5-minutes and were measured three times in a 
supine position, once in standing position, and twice in sitting position with 5-minute intervals, and the 
arithmetic mean of all available measurements was taken. Incident hypertension was ascertained through 
record linkage to the National Hospital Discharge Registry and the Social Insurance Institution of Finland 
register, which contains information on the reimbursement of expenses for antihypertensive medication. 
There were no losses to follow-up. Hazard ratios (HRs) with 95% confidence intervals (CIs) were 
calculated using Cox proportional hazard models.  All statistical analyses were conducted using Stata 
version 14 (Stata Corp, College Station, Texas). 
The mean age of participants at study entry was 52 [standard deviation (SD), 5] years. The baseline 
mean (SD) level of VO2 at VT was 24.57 (6.13) ml/kg/min and the corresponding level as metabolic 
equivalent was 7.02 (1.75). There were weak to moderate inverse correlations of VO2 at VT with several 
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risk markers. Significant positive correlations were observed with peak VO2 (r = 0.90), high-density 
lipoprotein cholesterol (HDL-C) (r = 0.26) and physical activity (r = 0.14). Similar correlations were 
observed for peak VO2 with several risk markers including HDL-C (r=0.28) and physical activity 
(r=0.15). During a median follow-up of 25.1 (interquartile range, 19.4-26.9) years, 217 new onset 
hypertension cases were recorded. The age-adjusted HR (95% CIs) per unit increase in VO2 at VT for 
hypertension was 0.95 (0.93-0.97), which remained unchanged on further adjustment for systolic blood 
pressure, smoking status, history of diabetes mellitus, family history of hypertension, total cholesterol, 
HDL-C, alcohol consumption, and physical activity 0.95 (0.93-0.98VO2 at VT was strongly and 
positively correlated with peak VO2. Alternatively, comparing the top versus bottom quartile of VO2 at 
VT, the corresponding age-, multivariate-, and multivariate plus peak VO2-adjusted HRs (95% CIs) for 
hypertension were 0.50 (0.33-0.76), 0.51 (0.33-0.78), and 1.31 (0.66-2.60) respectively (Table 1).  To put 
the strength of the association of VO2 at VT with risk of hypertension into context, direct comparisons 
were made to the association of peak VO2 with risk of hypertension. Similarly, peak VO2 was inversely 
and independently associated with hypertension risk as shown in Table 1. This association remained 
significant after further adjustment for VO2 at VT. 
Based on this population-based prospective cohort study of apparently healthy middle-aged Finnish 
men without a history of hypertension at baseline, we have shown an inverse association between VO2 at 
VT and future hypertension risk, which was independent of several established risk factors and other 
potential confounders; however, the association was dependent on peak VO2. Consistent with previous 
findings, VO2 at VT was strongly and positively correlated with peak VO2 VO2 at VT was shown to be 
strongly and positively correlated with peak VO2. In contrast, an analysis in the same set of participants 
showed the inverse association between peak VO2 and hypertension risk to be stronger and was also 
independent of VO2 at VT; which suggests that peak VO2 is a stronger risk indicator for hypertension risk 
than VO2 at VT.  
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To our knowledge, no previous study has evaluated the prospective association VO2 at VT with risk of 
hypertension, therefore we are unable to compare the current results with previous work. However, given 
that VO2 at VT is strongly correlated with peak VO2, with both parameters being measures of aerobic 
capacity;1, 7, 10 the current results are in line with previous reports that have demonstrated peak VO2  to be 
associated with the risk of developing future hypertension.4, 5 
It has been reported that VO2 at VT is more strongly correlated with endurance compared with peak 
VO2.
11 Though there has been emerging evidence on the potential application of CPX parameters in 
clinical practice,7 their use in general population settings have not been well established. VO2 at VT can 
be assessed safely at submaximal exercise levels, unlike peak VO2 which can be difficult to assess 
sometimes as a maximal exercise level needs to be achieved.12 Though peak VO2 remained the best 
indicator of hypertension risk, our findings do suggest that VO2 at VT could be used as a proxy marker 
when peak VO2 cannot be achieved due to other limitations. 
Our report is the first prospective evaluation of the association between VO2 at VT and the risk of 
future hypertension. Other strengths include the well-established cohort and long-term follow-up. The 
assessment of VO2 at VT during exercise test may have potential applications in clinical settings such as 
the detection of at risk patients. However, our results cannot be generalized to women and other 
populations. In addition, we could not correct for regression dilution because of absence of repeat 
measurements of VO2 at VT, which could have underestimated our associations. Thus, further studies are 
needed to clarify the role of VO2 at VT as a risk assessment tool for adverse cardiovascular outcomes 
such as hypertension.  
In conclusion, VO2 at VT is inversely associated with future risk of hypertension in middle-aged 
Caucasian men. The prognostic value of VO2 at VT for future hypertension deserves further study. 
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Table 1. Associations of VO2 at VT and peak VO2 with incident hypertension  
 
 Events / 
Participants 
Model 1  Model 2  Model 3  
  Hazard ratio (95% CI) P-value Hazard ratio (95% CI) P-value Hazard ratio (95% CI) P-value 
VO2 at VT and incident hypertension 
Per unit (ml/kg/min) 217 / 1,360 0.95 (0.93-0.97) < 0.001 0.95 (0.93-0.98) < 0.001 1.02 (0.96-1.07) 0.551 
Per 1 MET 217 / 1,360 0.83 (0.77-0.91) < 0.001 0.84 (0.76-0.92) 0.003 1.06 (0.88 - 1.28) 0.551 
Quartile 1 (6.90-20.31) 58 / 340 1 [Reference]  1 [Reference]  1 [Reference]  
Quartile 2 (20.32-24.03) 72 / 340 1.06 (0.75-1.50) 0.748 1.01 (0.71-1.44) 0.943 1.40 (0.94-2.08) 0.101 
Quartile 3 (24.04-28.35) 47 / 340 0.66 (0.45-0.97) 0.036 0.72 (0.49-1.08) 0.111 1.24 (0.75-2.07) 0.399 
Quartile 4 (28.36-52.21) 40 / 340 0.50 (0.33-0.76) 0.001 0.51 (0.33-0.78) 0.002 1.31 (0.66-2.60) 0.436 
P-value for trend   < 0.001  < 0.001  0.538 
        
Peak VO2  and incident hypertension 
Per unit (ml/kg/min) 217 / 1,360 0.95 (0.93-0.97) < 0.001 0.95 (0.93-0.97) < 0.001 0.94 (0.89-0.98) 0.005 
Per 1 MET 217 / 1,360 0.82 (0.77-0.88) < 0.001 0.83 (0.77-0.90) < 0.001 0.80 (0.68-0.93) 0.005 
Quartile 1 (10.25-27.43) 67 / 340 1 [Reference]  1 [Reference]  1 [Reference]  
Quartile 2 (27.44-32.22) 64 / 340 0.83 (0.59-1.17) 0.285 0.81 (0.57-1.16) 0.250 0.84 (0.57-1.24) 0.380 
Quartile 3 (32.26-36.94) 51 / 340 0.58 (0.40-0.85) 0.004 0.62 (0.42-0.91) 0.014 0.66 (0.40-1.08) 0.101 
Quartile 4 (36.97-65.40) 35 / 340 0.36 (0.24-0.55) < 0.001 0.38 (0.24-0.59) < 0.001 0.42 (0.21-0.86) 0.018 
P-value for trend   < 0.0001  < 0.0001  0.022 
 
Model 1: Adjusted for age 
Model 2: Model 1 plus systolic blood pressure, smoking status, history of diabetes mellitus, family history of hypertension, total cholesterol, high-density lipoprotein cholesterol, 
alcohol consumption, and physical activity 
Model 3: Model 1 plus peak VO2 (for VO2 at VT) or VO2 at VT (for peak VO2) 
VO2 at VT, oxygen uptake at ventilatory threshold  
1 MET is equivalent to 3.5 ml/kg/min of oxygen uptake at ventilatory threshold 
 
